title: Diagnostic relevance of plasma DNA and DNA integrity for breast cancer.
abstract: Levels of ALU 115, ALU 247, DNA integrity ([1, 2]) and of the tumour markers CA 15-3 and CEA were analysed in the blood of 152 patients. Plasma levels of ALU 115 and ALU 247 were significantly higher in patients with locally confined (LBC; N = 65), metastatic breast cancer (MBC; N = 47), and benign diseases (N = 12) than in healthy controls (p < 0.001 for all comparisons). DNA integrity, CEA, and CA 15-3 were significantly higher in MBC than in benign controls and LBC but could not identify LBCs. The best discrimination of LBC from healthy controls was achieved by ALU 115 and ALU 247 (AUC 95.4 and 95.5 %) and of MBC from all control groups by CA 15-3 and CEA (AUC 83.2 and 79.1 %). Plasma DNA is valuable for the detection of LBC, while established tumour markers are most informative in MBC.
authors.affiliation: Hematology/Oncology Outpatient Centre Munich, Munich, Germany.
authors.forename: Oliver J
authors.initials: OJ
authors.lastname: Stötzer
authors.forename: Julia
authors.initials: J
authors.lastname: Lehner
authors.forename: Debora
authors.initials: D
authors.lastname: Fersching-Gierlich
authors.forename: Dorothea
authors.initials: D
authors.lastname: Nagel
authors.forename: Stefan
authors.initials: S
authors.lastname: Holdenrieder
mesh_terms: D000328:Adult; D020087:Alu Elements / Q000235:genetics*; D001943:Breast Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000235:genetics / Q000473:pathology; D002272:Carcinoembryonic Antigen / Q000097:blood*; D004247:DNA / Q000097:blood* / Q000737:chemistry; D053938:DNA Fragmentation; D005260:Female; D006801:Humans; D008875:Middle Aged; D018396:Mucin-1 / Q000097:blood*; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis
chemical_list: D002272:Carcinoembryonic Antigen; D018396:Mucin-1; D004247:DNA
references.citation: Ann N Y Acad Sci. 2008 Aug;1137:207-13
references.pmid: 18837948
references.citation: Resuscitation. 2006 Jan;68(1):71-8
references.pmid: 16325316
references.citation: Anticancer Res. 2007 Jul-Aug;27(4A):1963-8
references.pmid: 17649806
references.citation: J Clin Oncol. 2006 Sep 10;24(26):4270-6
references.pmid: 16963729
references.citation: Mol Cancer. 2009 Nov 17;8:105
references.pmid: 19922604
references.citation: Clin Chem. 1998 Oct;44(10):2201-4
references.pmid: 9761259
references.citation: Ann N Y Acad Sci. 2008 Aug;1137:171-4
references.pmid: 18837943
references.citation: Ann N Y Acad Sci. 2008 Aug;1137:162-70
references.pmid: 18837942
references.citation: Crit Care Med. 2003 Jul;31(7):1947-51
references.pmid: 12847387
references.citation: Br J Cancer. 2004 Mar 22;90(6):1211-5
references.pmid: 15026803
references.citation: Gene. 2000 Dec 23;259(1-2):81-8
references.pmid: 11163965
references.citation: N Engl J Med. 2005 Oct 27;353(17):1784-92
references.pmid: 16251534
references.citation: Clin Chem. 2008 Dec;54(12):e11-79
references.pmid: 19042984
references.citation: Clin Chim Acta. 2010 Nov 11;411(21-22):1611-24
references.pmid: 20688053
references.citation: Ann N Y Acad Sci. 2006 Sep;1075:318-27
references.pmid: 17108227
references.citation: Cancer Biol Ther. 2005 Feb;4(2):139-63
references.pmid: 15725726
references.citation: Clin Cancer Res. 2002 Dec;8(12):3761-6
references.pmid: 12473587
references.citation: J Urol. 2009 Jan;181(1):363-71
references.pmid: 19010497
references.citation: Nat Rev Cancer. 2011 Jun;11(6):426-37
references.pmid: 21562580
references.citation: Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):5981-7
references.pmid: 15447981
references.citation: Clin Chem Lab Med. 2006;44(1):13-7
references.pmid: 16375578
references.citation: J Natl Cancer Inst. 2002 Nov 20;94(22):1697-703
references.pmid: 12441325
references.citation: DNA Cell Biol. 2008 Aug;27(8):415-21
references.pmid: 18694299
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Cancer Res. 2001 Feb 15;61(4):1659-65
references.pmid: 11245480
references.citation: Crit Rev Clin Lab Sci. 2009;46(1):1-24
references.pmid: 19107649
references.citation: Cancer Res. 2003 Jul 15;63(14):3966-8
references.pmid: 12873992
references.citation: Oncol Res. 2006;16(1):35-41
references.pmid: 16783966
references.citation: Clin Chem. 2006 Jun;52(6):1062-9
references.pmid: 16723681
references.citation: Pancreas. 1998 Jul;17(1):89-97
references.pmid: 9667526